Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2007
11/21/2007CN101076521A Process for producing muscarine receptor antagonist and intermediate therefor
11/21/2007CN101076514A Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
11/21/2007CN101076372A Use of compounds for the prevention of drug-induced cell toxicity
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/21/2007CN101076331A Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN101073668A Antibody compositions for selectively inhibiting vegf
11/21/2007CN101073665A Use of lymphotoxin in treatment of medicine for increasing chemoradiotherapeutic sensitivity
11/21/2007CN101073652A Chinese-medicinal pillow for treating chronic effort syndrome and its production
11/21/2007CN101073565A Use of arginine and taurine composition in anti-hypoxia medicine and health food
11/21/2007CN101073429A Zanghonghua Chinese-medicinal beverage
11/21/2007CN101073428A Hongjingtian Chinese-medicinal beverage
11/21/2007CN101073345A Oxygen-resisting tea
11/21/2007CN101073330A Appetizing Baxian cake
11/21/2007CN100349920C Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours
11/21/2007CN100349919C Monoclonal antibody and its preparing process and usage
11/21/2007CN100349893C Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007CN100349888C Medicine compound
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349868C Novel indoline compound and medicinal use thereof
11/21/2007CN100349856C Propionic acid derivatives and their use as hPPARs activators
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297799 Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297787 E.g., (2S, 3S, 4R, 5R)-2-(5-tert-butyl-[1,3,4]oxadiazol-2-yl)-5-[6-(4-chloro-2-fluoro-phenylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol, by aminating a 6-halopurine ribofuranose nucleoside in the presence of CaCO3 , wherein acid is added to the reaction mixture.
11/20/2007US7297774 Isolated or purified mutated human fibroblast growth factor receptor-4 (FGFR-4) comprising point mutation resulting in replacement of glycine with arginine; tyrosine kinase inhibitors; anticarcinogenic agents
11/20/2007US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists
11/20/2007US7297699 Piperazine and piperidine compounds
11/20/2007US7297697 4-(diarylmethyl)-1-piperazinyl derivatives
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297694 central nervous system disorders; traumas; anticancer agents; neurodegenerative agents; analgesics; headaches and cardiovascular disorders
11/20/2007US7297693 furan-, pyrrole- or thiophenecarboxamides ring-substituted with a hydroxyimino-fused ring and a nitrogen heteroarene; e.g., 5-[5-(1-Morpholin-4-yl-methanoyl)-2-pyridin-4-yl-furan-3-yl]-indan-1-one oxime;treating neurotraumatic diseases, cancer, neurodegeneration, pain, migraine and cardiac hypertrophy
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297542 Virology and gene therapy; modified fiber knob retains its ability to trimerize and retains its native biosynthesis profile
11/20/2007US7297539 Using nutrient broth comprising cell proliferative agents and mouse embryonic fibroblasts to propagating pluripotent stem cells for use in cell replacement therapies
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297509 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
11/20/2007CA2300289C A pharmaceutical composition active in reducing production of mcp-1 protein
11/20/2007CA1341561C Manufacture and expression of large structural genes
11/15/2007WO2007131238A2 Compounds and methods for modulating expression apob
11/15/2007WO2007131237A2 Compounds and methods for modulating expression of ptp1b
11/15/2007WO2007130842A2 Combination therapy for diseases involving angiogenesis
11/15/2007WO2007130403A2 REGULATION OF ApoB BY Hspl 10 PROTEINS AND RELATED COMPOSITIONS AND METHODS
11/15/2007WO2007129745A1 Heteroarylamide lower carboxylic acid derivative
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129668A1 Pyrazolyl 5-thioglucoside compound
11/15/2007WO2007129646A1 Macrolide derivative
11/15/2007WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof
11/15/2007WO2007129522A1 Preparation produced by dry process
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129457A1 Therapeutic agents for alzheimer's disease and cancer
11/15/2007WO2007129406A1 Degranulation inhibitor
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265436 Nucleotide sequences coding tumor-associated antigenic target polypeptide specific immunoglobulins for use in detection and prevention of cell proliferative disorders
11/15/2007US20070265355 Polyketal polymers, and methods of making and using same
11/15/2007US20070265348 Therapeutic guanidines
11/15/2007US20070265345 Novel Biphenyl Compounds And Their Use
11/15/2007US20070265331 Such as (2S)-2-(3(S)-Acetylamino-3-((S)-sec-butyl)-2-oxo-pyrrolidin-1-yl)-N-[(1S,2R)-1-(3,5-difluoro-benzyl)-2-hydroxy-3-(3-methoxy-benzylamino)-propyl]-4-phenyl-butyramide; inhibit processing of amyloid precursor proteins
11/15/2007US20070265325 Nitro Indazole Derivatives
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265319 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
11/15/2007US20070265292 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; anticarcinogenic and antproliferative agent; angiogenesis inhibitor
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265279 Use of mGluR5 antagonists for the treatment of pruritic conditions
11/15/2007US20070265274 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-ret kinase associated diseases
11/15/2007US20070265271 (8-Methyl-3,8-diaza-bicyclo[3.2.1]oct-3-yl)-[5-(4-nitro-phenyl)-furan-2-yl]-methanone; cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; nervous system diseases; inflammation, pain; drug addiction
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265260 Quinazoline derivatives
11/15/2007US20070265253 non-steroidal antiinflammatory agents such as 4H-Pyrido[2,3-g][1,4]benzothiazine-5,10-dione-1,1-dioxo-7-carboxylic acid, useful for treating inflammatory diseases or disorders
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265245 S-Mirtazapine For The Treatment Of Hot Flush
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/15/2007US20070265238 Method for accelerating reentrainment of a circadian rhythm
11/15/2007US20070265228 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
11/15/2007US20070265212 Drug Transport and Delivery System
11/15/2007US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/15/2007US20070265194 Agents for the treatment of viral infections
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070265185 Phosphorylated Vimentin Serving as a Marker of the Aggressiveness and/or Invasiveness of Tumors
11/15/2007US20070264417 Procyanidins; cleaning cocoa beans, heating unroasted cocoa nibs to loosen shells, winnowing the nibs from the shells, extracting with a polar solvent, a non-polar solvent, or a supercritical fluid
11/15/2007US20070264373 Toxin Induced Sympathectomy
11/15/2007US20070264359 administering an effective amount of an aqueous or alcohol extract of Phyllanthus to a mammal infected with the YMDD hepatitis B virus mutant strain resistant; inhibiting viral gene expression in a mammal infected with a hepatitis B virus
11/15/2007US20070264351 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
11/15/2007US20070264337 Compositions and methods for the induction and maintenance of quality sleep
11/15/2007US20070264289 Compositions and methods of administering doxepin to mucosal tissue
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264273 Sphingoid polyalklamine conjugates, isomers and uses thereof
11/15/2007US20070264259 Methods for treating kidney disorders
11/15/2007US20070264249 Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases
11/15/2007US20070264244 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
11/15/2007US20070264237 Use of Il-18 Binding Protein in Inflammations
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264198 Tumor necrosis agent
11/15/2007US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007US20070261695 Sublingual fentanyl spray
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 1564